Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Surfaxin
Descriptions
Lucinactant injection is used to prevent respiratory distress syndrome (RDS) in premature infants at risk for RDS. RDS is a breathing or lung problem which is more common in premature infants because their lungs are not making enough surfactant. Surfactant is a liquid produced naturally in the lungs that helps an infant breathe air normally.
This medicine is to be given only by or under the direct supervision of a doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2021
Copyright © 2021 IBM Watson Health. Todos los derechos reservados. La información es para uso exclusivo del usuario final y no puede venderse, redistribuirse ni utilizarse de ninguna otra forma con fines comerciales.